TULSA patients were treated and discharged the same day.
Geoffrey A. Sonn, MD
Advertisement
Articles by Geoffrey A. Sonn, MD
The AI tool outperformed MRI in assessing for SVI.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
4
FDA approves first-line Zenflow system for the treatment of BPH
5
